531624 Stock Overview
Country Condo's Limited engages in the real estate business in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Country Condo's Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹6.29 |
| 52 Week High | ₹7.15 |
| 52 Week Low | ₹3.65 |
| Beta | 0.74 |
| 1 Month Change | 25.30% |
| 3 Month Change | 23.33% |
| 1 Year Change | 65.09% |
| 3 Year Change | 185.91% |
| 5 Year Change | 175.88% |
| Change since IPO | -37.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531624 | IN Real Estate | IN Market | |
|---|---|---|---|
| 7D | 23.1% | 2.9% | 1.8% |
| 1Y | 65.1% | 115.6% | 46.4% |
Return vs Industry: 531624 underperformed the Indian Real Estate industry which returned 115.6% over the past year.
Return vs Market: 531624 exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
| 531624 volatility | |
|---|---|
| 531624 Average Weekly Movement | 8.1% |
| Real Estate Industry Average Movement | 7.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531624 has not had significant price volatility in the past 3 months.
Volatility Over Time: 531624's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 77 | Datla Krishna Raju | www.countrycondos.co.in |
Country Condo's Limited engages in the real estate business in India. It develops and sells residential layouts; and constructs compound walls, etc. The company was formerly known as Neocure Therapeutics Ltd. and changed its name to Country Condo's Limited in December 2006.
Country Condo's Limited Fundamentals Summary
| 531624 fundamental statistics | |
|---|---|
| Market cap | ₹492.74m |
| Earnings (TTM) | ₹17.91m |
| Revenue (TTM) | ₹254.85m |
27.5x
P/E Ratio1.9x
P/S RatioIs 531624 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531624 income statement (TTM) | |
|---|---|
| Revenue | ₹254.85m |
| Cost of Revenue | ₹122.34m |
| Gross Profit | ₹132.51m |
| Other Expenses | ₹114.60m |
| Earnings | ₹17.91m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 52.00% |
| Net Profit Margin | 7.03% |
| Debt/Equity Ratio | 8.2% |
How did 531624 perform over the long term?
See historical performance and comparison